Register for Digital Look

PureTech Health's Vor wins FDA fast-track approval for cancer drug

By Frank Prenesti

Date: Friday 10 Sep 2021

(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
The US Food and Drug Administration granted the designation to VOR33, a hematopoietic stem cell therapeutic candidate for the treatment of acute myeloid leukaemia.


Email this article to a friend

or share it with one of these popular networks:

Top of Page